Talaria Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.9M Sell
1,656,200
-123,900
-7% -$3.24M 8.53% 5
2026
Q1
$50M Hold
1,780,100
10.09% 5
2025
Q4
$44.3M Buy
1,780,100
+445,900
+33% +$11.2M 8.49% 7
2025
Q3
$34M Hold
1,334,200
6.12% 9
2025
Q2
$32.3M Buy
+1,334,200
New +$31.1M 7.64% 8

Other funds holding PFE

Talaria Asset Management's PFE Position: Q2 2026 in Review

Talaria Asset Management reduced its Pfizer (PFE) stake by 7% in Q2 2026, selling an estimated $3.24M and leaving 1,656,200 shares worth $39.9M. The position accounts for 8.53% of the portfolio, ranked #5.

Talaria Asset Management first reported a position in PFE in Q2 2025 and has held it in 5 quarters since. The position peaked at $50M in Q1 2026. 2,814 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Talaria Asset Management held 1,656,200 shares of Pfizer worth $39.9M as of Q2 2026.
  • Talaria Asset Management sold 123,900 Pfizer shares in Q2 2026, an estimated $3.24M.
  • Pfizer made up 8.53% of Talaria Asset Management's portfolio in Q2 2026, its #5 holding.
  • Talaria Asset Management first reported a position in Pfizer in Q2 2025 and has held it in 5 quarters since.
  • Talaria Asset Management's Pfizer position peaked at $50M in Q1 2026.
  • 2,814 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Talaria Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.